LIQUID PROTEIN COMPOSITIONS CONTAINING VISCOSITY-REDUCING AGENTS Russian patent published in 2022 - IPC A61K9/08 A61K39/395 A61K47/12 A61K47/20 A61G3/00 C07K1/14 

Abstract RU 2782765 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to protein compositions with low viscosity. A liquid pharmaceutical composition for injection contains from 183 to 215 mg/ml of a monoclonal antibody with molecular weight from 120 to 250 kDa; cimetidine or its pharmaceutically acceptable salt; and a pharmaceutically acceptable solvent; where the liquid pharmaceutical composition, when being in a volume suitable for injection, has absolute viscosity from 1 to 100 cP at 25°C, as measured using a viscometer with a cone and a plane or a microfluid viscometer; and absolute viscosity of the liquid pharmaceutical composition is less than absolute viscosity of the reference composition containing an antibody and a pharmaceutically acceptable solvent and not containing cimetidine or its pharmaceutically acceptable salt; where absolute viscosity is extrapolated viscosity at a zero shear rate. A method for administration to a subject of therapeutically effective amount of an antibody, a method for production of a liquid pharmaceutical composition, and a lyophilized composition are also disclosed.

EFFECT: group of inventions provides for quick and convenient administration by means of subcutaneous or intramuscular injection.

21 cl, 9 dwg, 40 tbl, 28 ex

Similar patents RU2782765C2

Title Year Author Number
LIQUID COMPOSITIONS OF PROTEINS CONTAINING AGENTS FOR VISCOSITY REDUCTION 2014
  • Larson, Alissa M.
  • Lav, Kevin
  • Uejt, Alisha K.
  • Krejn, Alan
  • Langer, Robert S.
  • Klibanov, Aleksander M.
RU2710542C2
LIQUID PROTEIN FORMULATIONS CONTAINING IONIC LIQUIDS 2014
  • Uejt Alisha K.
  • Larson Alissa M.
  • Langer Robert S.
  • Klibanov Aleksander M.
  • Lav Kevin
  • Krejn Alan
RU2675824C2
CONCENTRATED PROTEIN PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION 2011
  • Chen Trejsi T.
RU2626512C2
ANTIBODY FORMULATIONS 2012
  • Deshmukkh Adzhaj
  • Zejd Dzhumana
  • Sherer Tomas M.
RU2665810C2
NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT 2019
  • Olmiere, Celine
  • Mercier, Fabrice
RU2806096C2
HIGHLY CONCENTRATED COMPOSITIONS OF MONOCLONAL ANTIBODIES 2013
  • Armstrong Nikolas Dzh.
  • Bauen Mayumi N.
  • Maa Yuj-Fan
RU2711089C2
PHARMACEUTICAL FORMULATION CONTAINING BEVACIZUMAB 2021
  • Liu, Mujun
  • Fang, Yuan
  • Han, Dongmei
RU2819797C1
METHOD AND COMPOSITION FOR REDUCTION OF MICROMOLECULE AGGREGATION UNDER PHYSIOLOGICAL CONDITIONS 2009
  • Lobo Brajan
  • Lo Sabrina
  • Vang Juchang Dzhon
  • Vong Rita
RU2563823C2
COMPOSITION CONTAINING ANTIBODY 2010
  • Gokarn Yatin R.
  • Kamertsell Timoti Dzh.
  • Li Megan
  • Kromvell Meri
  • Lyu Khong
RU2609658C2
SELECTION OF MEDICATIONS FOR LUNG CANCER THERAPY BY MEANS OF ANTIBODY-BASED MATRICES 2008
  • Singkh Sharat
  • Kharvi Zhanna
RU2519647C2

RU 2 782 765 C2

Authors

Larson, Alissa M.

Lav, Kevin

Uejt, Alisha K.

Krejn, Alan

Langer, Robert S.

Klibanov, Aleksander M.

Dates

2022-11-02Published

2014-09-11Filed